Sunshine Biopharma Stock Forecast

Buy candidate since Jun 23, 2026

The Sunshine Biopharma, Inc. stock price gained 123.63% on the last trading day (Tuesday, 23rd Jun 2026), rising from $0.0402 to $0.0899. During the last trading day the stock fluctuated 246.86% from a day low at $0.0700 to a day high of $0.243. The price has been going up and down for this period, and there has been a 212.15% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 75 thousand more shares were traded than the day before. In total, 78 thousand shares were bought and sold for approximately $6.97 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -45.63% during the next 3 months and, with a 90% probability hold a price between $0.0057 and $0.0644 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SBFMW Signals & Forecast

Mostly positive signals in the chart today. The Sunshine Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0526 and $0.0770. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 09, 2026, and so far it has risen 259.60%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Sunshine Biopharma, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0821 and $0.0713. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Sunshine Biopharma, Inc. finds support just below today's level at $0.0821. If this is broken, then the next support from accumulated volume will be at $0.0713 and $0.0698.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.173 between high and low, or 246.86%. For the last week, the stock has had daily average volatility of 216.82%.

Our recommended stop-loss: $0.0865 (-3.82%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (SBFMW) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Sunshine Biopharma, Inc. to open at $0.134, and during the day (based on 14 day Average True Range), to move between $0.0363 and $0.143, which gives a possible trading interval of +/-$0.107 (+/-294.71%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 294.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0921 (2.45%) than the support at $0.0821 (8.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sunshine Biopharma, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Buy candidate.

Current score: 4.532 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.134 ( 49.31%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk